References of "REGINSTER, Jean-Yves"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailRecommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma
Holgate, ST; Bousquet, J; Chung, KF et al

in International Journal of Pharmaceutical Medicine (2002), 16

Detailed reference viewed: 4 (1 ULg)
Peer Reviewed
See detailL'audit en médecine générale : outils de dépistage et d'intervention
Filée, Dominique ULg; Gosset, Christiane ULg; Dor, B et al

Conference (2002)

Detailed reference viewed: 16 (3 ULg)
Full Text
Peer Reviewed
See detailModels for assessing the cost-effectiveness of the treatment and prevention of osteoporosis
Zethraeus, N.; Ben Sedrine, Wafa ULg; Caulin, F. et al

in Osteoporosis International (2002), 13(11), 841-857

Detailed reference viewed: 70 (15 ULg)
Full Text
Peer Reviewed
See detailOsteoporosis in the very elderly
Halkin, V; Bruyère, Olivier ULg; Reginster, Jean-Yves ULg

in Medicographia (2002), 24(4), 316-321

Detailed reference viewed: 8 (4 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate in osteoporosis
Reginster, Jean-Yves ULg

in Current Pharmaceutical Design (2002), 8

Detailed reference viewed: 4 (3 ULg)
Full Text
Peer Reviewed
See detailNew perspectives n the medical management of osteoarthritis
Reginster, Jean-Yves ULg

in Osteoarthritis and Cartilage (2002), 10(SA), 18-19

Detailed reference viewed: 4 (1 ULg)
Full Text
Peer Reviewed
See detailPain relief is not a confounder in joint space narrowing assessment of full extension knee radiographs
Pavelka, K.; Rovati, L. C.; Gatterova, J. et al

in Osteoarthritis and Cartilage (2002), 10(SA), 16-17

Detailed reference viewed: 12 (5 ULg)
Full Text
Peer Reviewed
See detailDose-related bone effects of strontium ranelate in postmenopausal women
Meunier, P. J.; Reginster, Jean-Yves ULg

in Osteoporosis International (2002), 13(S1), 153

Detailed reference viewed: 4 (2 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate antifracture study program : current data
Reginster, Jean-Yves ULg; Meunier, P. J.

in Osteoporosis International (2002), 13(S1), 153-154

Detailed reference viewed: 2 (1 ULg)
Full Text
Peer Reviewed
See detailThe effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis.
Ethgen, Olivier ULg; Kahler, Kristijan H; Kong, Sheldon X et al

in Journal of Rheumatology (2002), 29(6), 1147-55

OBJECTIVE: In today's cost conscious environment, health services researchers are consistently trying to find ways to predict future health care resource utilization (HCRU) and its associated costs. We ... [more ▼]

OBJECTIVE: In today's cost conscious environment, health services researchers are consistently trying to find ways to predict future health care resource utilization (HCRU) and its associated costs. We evaluated the impact of health related quality of life (HRQL) on future HCRU in patients with arthritis. METHODS: A total of 642 patients with rheumatoid arthritis (RA) and 395 patients with osteoarthritis (OA) completed at least 2 and as many as 6 consecutive surveys at 6 mo intervals. Information collected included demographics, HRQL questionnaires [Medical Outcome Study Short Form 36 (SF-36), Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), and the Stanford Health Assessment Questionnaire (HAQ)], and HCRU over the previous 6 months. Longitudinal data analysis was perfomed to assess the effect of HRQL on future HCRU. RESULTS: Statistically significant associations between HCRU and HRQL variables were noted. Higher rates of HCRU were found in those in the worst quarter compared with those in the best quarter of HRQL. With the HAQ, OA and RA patients in the worst quarter reported a 199% (p < 0.05) and 48% (p < 0.05) increase in rheumatologist visits, respectively. With the WOMAC Function, increases were as high as 196% (p < 0.05) in rheumatologist visits for patients with OA. Patients with RA with a high level of HRQL as measured by the SF-36 (physical component score) reported a decrease of 31% (p < 0.01) in general practitioner visits and a decrease of 52% (p < 0.01) in hospitalization (mental component score). CONCLUSION: These findings suggest that HRQL may be used to predict future health care consumption. Such an approach may lead to a more efficient allocation of resources by providing useful information to health care providers and health care decision makers. [less ▲]

Detailed reference viewed: 7 (3 ULg)
Full Text
Peer Reviewed
See detailCharacterization of the Metabolism of Osteoarthritic Chondrocytes Cultured in Alginate Beads
Sanchez, Christelle ULg; Mathy, Marianne ULg; Deberg, Michelle ULg et al

in Osteoarthritis and Cartilage (2002), 10(SA), 34

Detailed reference viewed: 19 (11 ULg)
Full Text
Peer Reviewed
See detailStructure-modifying drugs in osteoarthritis
Reginster, Jean-Yves ULg; Kvasz, Angela ULg

in Osteoporosis International (2002), 13(Suppl. 1), 49-50

Detailed reference viewed: 23 (16 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate réduit le risque de fracture vertébrale chez des patientes traitées 3 ans pour ostéoporose postménopausique
Meunier, P. J.; Roux, C.; Fardellone, P. et al

in Revue du Rhumatisme (2002), 69

Detailed reference viewed: 7 (2 ULg)
Full Text
Peer Reviewed
See detailUsing the OST index to identify women at risk of osteoporosis : a validation study in Belgium
Ben Sedrine, Wafa ULg; Reginster, Jean-Yves ULg

in Osteoporosis International (2002), 13(S1), 109-110

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailPrediction of bone mineral density by estrogens precursors, estradiol, SHBG and BMI in elderly women at risk for osteoporotic fractures
Goemaere, S.; Zmierczak, H.; Van Pottelbergh, I. et al

in Osteoporosis International (2002), 13(S1), 102

Detailed reference viewed: 4 (1 ULg)
Full Text
Peer Reviewed
See detailComparison of quantitative ultrasound at the heel with a clinical risk factor score for the assessment of postmenopausal osteoporosis
Goemaere, S.; Zmierczak, H.; Lauwerier, D. et al

in Osteoporosis International (2002), 13(S1), 73-74

Detailed reference viewed: 4 (1 ULg)
Full Text
Peer Reviewed
See detailThe effect on bone turnover of monofluorophosphate (MFP) combined with raloxifene (RLX) as compared to MFP alone in postmenopausal women with low bone mass
Stepan, J.; Payer, J.; Resch, H. et al

in Osteoporosis International (2002), 13(S1), 54

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailA short-term run-in study can significantly contribute to increasing the quality of long-term osteoporosis trials. The strontium-ranelate phase 3 program
Reginster, Jean-Yves ULg; Spector, T.; Badurski, J. et al

in Osteoporosis International (2002), 13(S1), 30

Detailed reference viewed: 5 (1 ULg)